NanoViricides (NYSE-A:NNVC), a clinical-stage leader in broad-spectrum antiviral nanomedicines, announced that its executive chairman Anil Diwan will present at the The Partnership Opportunities in Drug Delivery (PODD) Conference.
The presentation will take place on Monday, October 28, 2024, at 3:45 PM at the Westin Boston Seaport District, MA.
Dr. Diwan will outline the NanoViricides (NYSE-A:NNVC) platform technology and its achievements, focusing on the transformative potential of the broad-spectrum antiviral drug candidate NV-387 against most respiratory viruses.